In an attempt to figure out why individuals with a limited capacity to exercise behave the way they do, a team of researchers conducted a case study. After several tests, including genetic analysis, the scientists found that the mutated gene being examined "was the von Hippel-Lindau (VHL) gene."
Under strict regulations, human genome editing may be endorsed by the government to curb the diseases. Designer babies may be termed unethical by some but gene editing holds the answers to many health problems.
College rivalries are nothing new. Some even reach legendary proportions. USC vs. Notre Dame, Alabama vs. Auburn, Army vs. Navy. They make for great football. Not so much when it comes to technological rights, as we're discovering in the ongoing battle between UC Berkeley and MIT, as they wrestle over the patent for a machine that just might revolutionize genetic engineering.
China has shocked the world and has since been ordered to "rein in" its scientists who have edited the DNA of human embryos for the first time, a practice that has been banned in many parts of the world.
When it comes to tackling important issues within the science community that address realistic needs of the public, few publications are quite as thoughtful as the journal Science when it comes to curating the best of the best research, in any given field. Though the journal often covers a wide breadth of topics, this week they’re headed in a new direction, talking about game-changing cancer immunotherapy and the future possibility of individualized treatments that will take every patient’s genetic makeup and mutations into consideration. And it has become a conversation led by many hopeful researchers at the helm, backed by promising data.
In an unprecedented study which involved the largest set of gemoes from a single human population, researchers found data suggesting that the "father of humanity" lived 100,000 earlier than previously thought.
While Post-traumatic stress disorder (PTSD) has become highly stigmatized as a mental health condition within the armed forces, where soldiers often return home from battle with the debilitating condition, it appears that not only may some soldiers be genetically predisposed to it—some may have immunological reactions that even make it worse. In a new study published this week in the journal Molecular Psychiatry, a team of researchers with the University of Southampton (UK) and University of California, San Diego have uncovered the genetic markers that could theoretically allow them to identify soldiers or patients that may be most at risk, even before they’re deployed at all.